AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Ozguroglu, M Arun, B Demir, G Demirelli, F Mandell, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Serum erythropoietin level in anemic cancer patients, MED ONCOL, 17(1), 2000, pp. 29-34

Authors: Ozduroglu, M Arun, B Erzin, Y Demir, G Demirelli, F Mandel, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozduroglu et al., Serum cardiolipin antibodies in cancer patients with thromboembolic events, CL APPL T-H, 5(3), 1999, pp. 181-184

Authors: Baltali, E Gunel, N Onat, DA Atahan, IL Akcali, Z Buyukunal, E Firat, D
Citation: E. Baltali et al., Neoadjuvant chemotherapy in locally advanced breast cancer: A preliminary report, TUMORI, 85(6), 1999, pp. 483-487

Authors: Ozguroglu, M Turna, H Demir, G Doventas, A Demirelli, F Mandel, NM Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma, AM J CL ONC, 22(6), 1999, pp. 615-618

Authors: Demir, G Ozguroglu, M Sayhan, N Molinas-Mandel, N Demirelli, F Buyukunal, E Tuzuner, N Serdengecti, S Berkarda, B
Citation: G. Demir et al., Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study), ANTICANC R, 19(4C), 1999, pp. 3517-3520

Authors: Ozguroglu, M Ozaras, R Tahan, V Demirkesen, C Demir, G Dogusoy, G Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Anorectal melanoma metastatic to the breast, J CLIN GAST, 29(2), 1999, pp. 197-199

Authors: Ozguroglu, M Celik, AF Demir, G Aki, H Demirelli, F Mandel, N Buyukunal, E Serdengecti, S Berkarda, B
Citation: M. Ozguroglu et al., Primary splenic tuberculosis in a patient with nasal angiocentric lymphoma- Mimicking metastatic tumor on abdominal CT, J CLIN GAST, 29(1), 1999, pp. 96-98

Authors: Demir, G Demirelli, F Ozguroglu, M Molinas-Mandel, N Buyukunal, E Tuzuner, N Serdengecti, S Berkarda, B
Citation: G. Demir et al., Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma, INT J IMM T, 14(3), 1998, pp. 163-168
Risultati: 1-8 |